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Substance use in pregnancy is not uncommon and the use of substances increases the 
risk of complications during pregnancy and of birth defects.
Vermont PRAMS data from 2012 indicated that 14% of women drank alcohol and 
16% of women smoked during the last trimester of pregnancy.  Despite these rates, 
only 66.5% of mothers reported that their healthcare provider had discussed illicit 
substance use and its side effects during their pregnancy.
During pregnancy, women can be highly motivated to change behaviors. One study 
found that 57% of pregnant women using illicit drugs abstained during pregnancy.
OPIATE ADDICTION IN PREGNANCY
According to the 2013 National Survey on Drug use, 5.4% of pregnant women 
reported illicit drug use in the past 30 days.
0.1% of pregnant women estimated to have used heroin
1.0% of pregnant women reported nonmedical use of opioid-containing medication
Infants exposed to opioids in utero are diagnosed as having neonatal abstinence 
syndrome (NAS) at birth.
OPIATE ADDICTION IN VERMONT
Neonates Exposed to Opioids in Vermont, Vermont 
Hospital Discharge Data Set, Vermont Department of 
Health, June 2015
Rate of emergency department visits 
related to opioids has sharply 
increased over the past 5 years.  The 
number of people in treatment 
receiving either buprenorphine or 
methadone has also increased.
Rates of infants exposed to opioids is 
also on the rise.
IMPACT ON THE FETUS
Nationally, neonatal abstinence syndrome 
(NAS) cases  have gone from 7 to 27 cases 
per 1000 NICU admissions between 2003 and 
2014.
In Vermont, infant hospital stay length is 
shortening but remains longer than in non-
opiate exposed infants.
Direct birth defects due to opiates are difficult to tease apart from coexisting medical, 
nutritional, psychological and socioeconomic issues. Multiple complications, however, have 
been associated with opiate use in pregnancy including:
Placental abruption, fetal death, intra-amniotic infection, fetal growth restriction, preeclampsia, 
premature labor, premature rupture of membranes, and septic thrombophlebitis
Neonates Exposed to Opioids in Vermont, Vermont Hospital Discharge 
Data Set, Vermont Department of Health, June 2015
COMMUNITY PERSPECTIVE
Julie Merrill, Learning Together Coordinator at the Springfield Area Parent Child 
Center
Discussed programs offered to moms requiring additional supports in the areas 
of work skills, life skills, and parenting skills as well as their childcare center, 
case management and Children’s Integrated Services (a comprehensive 
program through DCF that babies born with NAS get automatically referred 
to)
Lyndsy McIntyre, Nurse Manager of the ChildBirth Center at Springfield Hospital
Discussed resources available to opiate using pregnant women in Springfield, 
VT and the procedures in place for identifying opiate using women during 
prenatal care and during hospital stay
 Feels more information is needed for pregnant women using opiates
COMMUNITY PERSPECTIVE, CONT.
James Walsh, PMH-NP at Springfield Health Center
Discussed buprenorphine substitution therapy in pregnancy available through 
the Windham Center and learned about the role of community health 
workers in coordinating care of opiate using pregnant women
 Feels more resources are needed for primary care physicians on how to 
identify and better assist opiate-using mothers
Amelia Carson, Clinical Care Coordinator at The Women’s Health Center
Office performs drug screen on all pregnant woman as part of first prenatal 
visit.  The current struggle is bridging opiate replacement from when a mom 
needs help until she can be placed into a buprenorphine substitution program
DEVELOPMENT AND IMPLEMENTATION
In talking to community members in Springfield, VT I identified several 
challenges to good prenatal care in this population:
Pregnant moms may deny opiate use due to fear of legal consequences since 
Vermont mandates notifying the Department of Children and Families (DCF)
In the primary care office it is challenging to have a non-threatening and 
productive conversation on opiate use in pregnancy when suspected
Pregnant moms and providers alike may be unaware of the all the resources 
available to opiate using pregnant women in the area
PROJECT: COMPILATION OF RESOURCES FOR PRIMARY 
CARE PROVIDERS IN THE SPRINGFIELD AREA
Through discussions with community members in addition to identifying that opiate use 
in pregnancy is an issue, I learned that some women avoid seeking prenatal care due 
to fear of DCF involvement and the possibility that their child could be taken away.  I 
decided to put together a handout that explains what to expect during pregnancy as 
an opiate user.  
Many of the providers discussed the difficulty of finding buprenorphine prescribers so 
I also attempted to locate all the area prescribers and medically-assisted treatment 
programs within 1.5 hour drive of Springfield, VT.  This way the handout could be 
helpful to providers and patients.
The handout will be available for distribution at Turning Point, The ChildBirth Center, 
and at a few sites associated with the Springfield Health Center including PCP offices 
and the Women’s Health Center.
EVALUATION OF EFFECTIVENESS
In order to evaluate the effectiveness of this handout one could:
•Measure if there is an increase in pregnant women using opiates that seek prenatal 
care in Springfield, VT
•Measure the number of pregnant women seeking buprenorphine or methadone 
treatment
•Measure increased enrollment at the Parent Child Center
LIMITATIONS AND FUTURE WORK
With this handout I struggled between providing all the information I felt was 
necessary and designing something that is brief and fits onto a smaller, less 
intimidating pamphlet. 
Next steps could include: educating PCPs to better screen for opiate misuse, providing 
information to PCPs about opiate use in pregnancy and the resources available, 
identifying other boundaries that prevent women using opiates from seeking prenatal 
care, improving access to transportation in Springfield so that more women can take 
advantage of area services, or coordinating with the BAMBI program in Rutland to 
see if Springfield could work to have a more centralized system for providing all the 
services necessary for pregnant women using opiates
REFERENCES
Chang, G. (2015). Overview of substance misuse in pregnancy. UpToDate. Retrieved December 21, 2015, from 
http://www-uptodate-com.ezproxy.uvm.edu/contents/overview-of-substance-misuse-in-pregnant
women?source=search_result&search=substance misuse in pregnant women&selectedTitle=1~150 
Committee on Health Care for Underserved Women and the American Society of Addiction Medicine. Opioid 
Abuse, Dependence, and Addiction in Pregnancy. (2012). Obstetrics & Gynecology, 119(5), 1070-75.
Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug 
Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-
4863. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.
Substance Abuse and Mental Health Services Administration, Behavioral Health Barometer Executive Summary, 
2014, http://www.samhsa.gov/data/sites/default/files/Region_1_Barometer_2014.pdf
Tolia VN, Patrick SW, Bennett MM, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. 
neonatal ICUs. N Engl J Med 2015; 372:2118.
Vermont Department of Health. Neonates Exposed to Opioids in Vermont. Vermont Uniform Hospital Discharge 
Data Set. June 2015. http://healthvermont.gov/research/documents/opioids_neonate_exposure.pdf
Vermont Department of Health. Pregnancy Risk Assessment Monitoring System (PRAMS). 2007 and 2012 
INTERVIEW CONSENT
Thank you for agreeing to be interviewed. This 
project is a requirement for the Family Medicine 
clerkship. It will be stored on the Dana Library 
ScholarWorks website. Your name will be 
attached to your interview and you may be cited 
directly or indirectly in subsequent unpublished 
or published work. The interviewer affirms that 
he/she has explained the nature and purpose of 
this project. The interviewee affirms that he/she 
has consented to this interview. Yes ___x__ / 
No _____ 
If not consenting as above: please add the 
interviewee names here for the department of 
Family Medicine information only. 
Name: James Walsh
Thank you for agreeing to be interviewed. This 
project is a requirement for the Family Medicine 
clerkship. It will be stored on the Dana Library 
ScholarWorks website. Your name will be 
attached to your interview and you may be cited 
directly or indirectly in subsequent unpublished or 
published work. The interviewer affirms that 
he/she has explained the nature and purpose of 
this project. The interviewee affirms that he/she 
has consented to this interview. Yes __x___ / No 
_____ 
If not consenting as above: please add the 
interviewee names here for the department of 
Family Medicine information only. 
Name: Lyndsy McIntyre
INTERVIEW CONSENT
Thank you for agreeing to be interviewed. This 
project is a requirement for the Family Medicine 
clerkship. It will be stored on the Dana Library 
ScholarWorks website. Your name will be 
attached to your interview and you may be cited 
directly or indirectly in subsequent unpublished 
or published work. The interviewer affirms that 
he/she has explained the nature and purpose of 
this project. The interviewee affirms that he/she 
has consented to this interview. Yes ___x__ / 
No _____ 
If not consenting as above: please add the 
interviewee names here for the department of 
Family Medicine information only. 
Name: Julie Merrill
Thank you for agreeing to be interviewed. This 
project is a requirement for the Family Medicine 
clerkship. It will be stored on the Dana Library 
ScholarWorks website. Your name will be 
attached to your interview and you may be cited 
directly or indirectly in subsequent unpublished or 
published work. The interviewer affirms that 
he/she has explained the nature and purpose of 
this project. The interviewee affirms that he/she 
has consented to this interview. Yes __x___ / No 
_____ 
If not consenting as above: please add the 
interviewee names here for the department of 
Family Medicine information only. 
Name: Amelia Carson
